Submission of a manuscript to International Clinical Neuroscience Journal imply that the research is original and not previously published, and that it is not being considered for publication elsewhere. Manuscripts submitted under multiple authors are reviewed on the assumption that all listed authors have agreed on the submission and that a copy of the final manuscript has been approved by all authors. Manuscripts are first reviewed by the section editors to ensure that they are relevant to the scope of the journal. The manuscript would be peer-reviewed by related specialists. If accepted, the article shall not be published elsewhere, without the consent of the Editors and Publisher.

Declaration of Copyright in the journal website

All manuscripts must adhere to our guidelines. Manuscripts should be no longer than 8000 words including the references  to be considered for publication. Articles should be written in English, and double spaced with wide margins. The layout and style should adhere strictly to the instructions given and in particular, the reference style of International Clinical Neuroscience Journal. The author(s) must consider the ethical consideration for studies with human subject or animal subject that described above and declare the related statement accordingly in the Method section of their manuscript.

Submission items include Cover Letter, Reviewer Suggestions (at least 3), Manuscript including Title Page, Abstract, Main text (Original Paper: Introduction, Materials and Methods, Results, and Discussion), Acknowledgements, References and Tables/Figure Legends, Tables and Figures. Text files (double-spaced) of the manuscript should be supplied in Microsoft Word format.


  • Type of Articles:


    • Original Articles: Observational studies (including cohort, case-control, and cross-sectional studies) should be arranged based on the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement and checklist. Research papers that report a randomized controlled trial, should comply with the guidelines provided by the Consolidated Standards of Reporting Trials (CONSORT) group. In addition, supplying the manuscript with a CONSORT flowchart diagram is highly encouraged. Researchers who would like to publish their clinical trial reports in this journal must register their studies in a registry of clinical trials. As an option, the Iranian Registry of Clinical Trials (IRCT) is a registry suggested by WHO for Iranian authors. Abstracts should not exceed 350 words and the main text (excluding abstract and references) should not exceed 4500 words for original papers.
    • Reviews: Review articles should be composed of systematic critical assessments of literature and data sources pertaining to clinical topics, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention. They should have unstructured abstracts. All articles and data sources should include information about the specific types of study or analysis, population, intervention, exposure and tests or outcomes. Authors of review articles should be expert and have contributions in the field of the addressed subject. Systematic reviews and meta-analyses on clinical trials and observational studies should be prepared based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE), respectively. Abstract should not exceed 350 words and the main text (excluding abstract and references) should not exceed 5000 words.
    • Case Reports: Case reports should be arranged in accordance with Consensus-based Clinical Case Reporting (CARE) as follows: Abstract (unstructured, not exceeding 150 words), Introduction, Case presentation, Discussion, Conclusion, Declarations, References, and Figures. Abstract should not exceed 150 words and the main text (excluding abstract and references) should not exceed 1000 words. At most 5 authors and 15 references could be included.
    • Brief Reports:Original research papers can also be published in a brief format. Submitted papers that are of interest but not acceptable as a full-length original/research article, are offered by the editor to be published in this section. The authors can also primarily submit their papers for consideration of publication in this section. An unstructured abstract no longer than 200 words is required for this section. The body of the manuscript should not exceed 2000 words and no heading or subheading should be used. The number of tables and/or figures should be limited to 2 and references to a maximum of 15. At most 4 authors could be included.
    • Letters to the Editor: All correspondence will be considered for publication if it contains constructive criticism on previously published articles in the journal, the authors of which will have the right of reply. In addition, reports of limited research or clinical experiences can be submitted in the form of a letter. The length should not exceed 700 words. Just one table or figure and references to a maximum of 10 are allowed. At most 3 authors could be included.
    • Editorial: Editorials are submitted exclusively by the host editor(s) of a Neuroscience Research Topic, to convey to the reader the aims and objectives of the research that pertains to the topic, as well as placing it in a broader context. The Editorial should present the contributing articles of the Research Topic but should not be a mere table of contents. As the final contributing article to the Research Topic, Editorials should be submitted once all expected articles have been accepted and published. Editorials should not include unpublished or original data and the inclusion of references is strongly encouraged. Editorial articles may contain 1 Figure and have a word count of 1,000 for Topics with 5-10 articles. The word limit can be increased for each additional article in the Topic, up to a maximum of 5,000 words for 50 articles or more. Topic editors are not required to pay a fee to publish an Editorial article. Submissions are required to have the title Editorial: "Title of Research Topic".

    • Correction: Corrigendum/Addendum: should author’s notice errors that affect the scholarly record or the integrity of the paper, authors are encouraged submitting a correction online. The correction must detail the reason(s) for the error(s) and include only the elements (e.g. sections, sentence, and figure) of the manuscript being revised or corrected. All authors of the original paper need to agree to the request for changes. The contribution to the field statement should be used to clearly state the reason for the Correction. Depending on the extent of the correction required, corrections may require peer review. Authors are informed that requests for changes beyond that described here may not be accepted for publication.

      Erratum: should authors notice differences between their approved galley proofs and the final published article, thus leading to errors that affect the scholarly record or the integrity of the paper, authors are encouraged to submit a request for erratum to the International Clinical Neuroscience Journal office ( ), clearly specifying the error and the correct information.


Title Page: This page should contain the following items: (i) complete title (preferably no chemical formulas or arbitrary abbreviations); (ii) full names of all authors; (iii) complete affiliations of all authors where you conducted the research; (iv) the number of text pages of the whole manuscript (including figures and tables) and the number of figures and tables; (v) running title; (vi) the name and complete address of the corresponding author (as well as telephone number, facsimile number and E-mail address, and ORCID ID) to whom correspondence and proofs should be sent. 

Running title: A maximum of 7 characters with spaces should be provided.

Abstract: Provide a succinct and factual abstract (maximum to 350 words) for your manuscript.
Abstract could be structured or unstructured. Structured abstract for "Original Article" should consist of four paragraphs including the background, methods, results, and conclusions. The abstract should state briefly, respectively, the problem being addressed in the study, how the study was performed, the salient results, and what the authors conclude from the results. Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined when they first mentioned in the abstract itself.

Keywords: A maximum of 7 keywords or phrases should be provided; preferably, these should be selected from the body of the text.

Main text: In general, the main text of the manuscript should be organized as follows: Introduction, Materials and Methods, Results, Discussion, Acknowledgements, and References.  


The list of references should be arranged and numbered in order of appearance in the text, not alphabetically. The appropriate number should be inserted as superscript in the text. The full titles of the quoted publications should be listed. List the first six authors followed by “et al.”. Examples:


Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347(4):284–7.


Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.

3. [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from:

A full list of examples can be found at the National Library of Medicine website.

Notes: Please check with Vancouver Style for any specific referencing or formatting requirements.


Illustrations: Illustrations will appear either across a single column (8 cm) or a whole page (15 cm). The illustrations should be supplied with a title, an explanatory legend and a number in Arabic numerals. The number of figures should be based on sequence of appearance in the text, where they are referred to as Fig. 1, Fig. 2, etc. Figure legends should be concise and clear and should not duplicate the body of the text.. The title should be part of the legend and not be reproduced on the figure itself. The legends should be placed on a separate page at the end of the manuscript and begin with the number of the illustration they refer to. All symbols and abbreviations used in the figure must be explained.  Also, please indicate their appropriate locations in the manuscript.


Tables:  Submit table as editable text not as image. Number tables consecutively in accordance with their appearance in the text and place  in Arabic numerals (Table 1, 2, etc.) and referred to in the text as Table 1, Table 2, etc. The title of the table should appear above it. A detailed description of its contents and footnotes should be given below the body of the table. Also, please indicate their appropriate locations in the manuscript through citation. 


Figures: Figures should be sent in a separate file.  Please do not imprint the figures in the word text. Descriptions for all figures should be included in the file with the text and should not appear on the figures. Pictures, photos, and figures must be submitted, in the acceptable form of GIF, JPG, PDF, PPT, and TIF files. If they are in MS Word format, they should be included in the manuscript file. Please describe and clearly indicate all modifications, selective digital adjustments, or electronic enhancements in all digital images. It is permissible to send low-resolution images for peer review, although we may ask for high-resolution files at a later stage.


Proof Reading: A computer prints out is sent to the corresponding author for proof reading before publication in order to avoid any mistakes. Corrections should be marked clearly and sent immediately to the Journal office.

Abbreviations and symbols: Use only standard abbreviations. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.


The Corresponding Author: The corresponding author should be the one and only person who is willing and able to manage all correspondence with the journal editor, including responding to reviewers’ comments and proofreading the final version. Only one corresponding author would be accepted for each article. Corresponding author is responsible for considering and providing carefully the list and order of authors before submitting the manuscript .. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the followings from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Authors are required to provide their ORCID numbers at submission.

Ethical guidelines: When reporting experiments on animals, authors should indicate whether the institutions or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed. When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983.

This means that the authors must make a clear statement that the laws which apply to them in their own country were followed.  Ethical considerations must be addressed in a separate paragraph at the end of the paper. Please state that informed consent was obtained from all human adult participants and from the parents or legal guardians of minors. Include the name of the appropriate institutional review board that approved the project.


Clinical Trials: Original research papers that report a randomized controlled trial, should comply with the guidelines provided by the Consolidated Standards of Reporting Trials (CONSORT) group. Also, supplying the manuscript with a CONSORT flowchart diagram is highly encouraged. Researchers who would like to publish their clinical trial reports in Emergency are strongly encouraged to register their studies in a registry of clinical trials proposed by the World Health Organization (WHO) or the International Committee of Medical Journal Editors (ICMJE). As an option, the Iranian Registry of Clinical Trials (IRCT) is a registry suggested by WHO.


Conflicts of Interest: Authors must acknowledge and declare any sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in, an organization that may profit or lose through publication of your paper. Declaring a competing interest will not lead to automatic rejection of the paper, but we would like to be made aware of it.


Acknowledgements: All contributors who do not meet the criteria for authorship according to ICMJE Criteria, such as a person who provided purely technical help, writing assistance, or a department chair who provided only general support should be listed in the acknowledgments. Financial and material support should also be recognized in the acknowledgments.


We encourage authors to supply ORCiD IDs during manuscript submission. See our ORCiD page for more information.